Skip to main content

MedAvail Holdings, Inc.

MDVLDelisted Mar 21, 2024
Industry
Retail-Drug Stores and Proprietary Stores
SEC CIK
0001402479

MedAvail Holdings, Inc. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 6, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $6.16M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by MedAvail Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for MedAvail Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for MedAvail Holdings, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Faulkner Robert C.Director–Feb 6, 20240
Seabaugh RamonaChief Financial Officer1,222Oct 2, 20230
Doerr Mark EdwardChief Executive Officer188,701Aug 21, 20230
Redmile Group, LLCDirector, 10% Owner19,097,796Jun 21, 20230
Green JeremyDirector, 10% Owner19,097,796Jun 21, 20230
RedCo II Master Fund, L.P.Director, 10% Owner19,097,796Jun 21, 20230
Yu Fan10% Owner5,894,897IndirectJun 21, 20230
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.10% Owner5,894,897IndirectJun 21, 20230
Ally Bridge Group (NY) LLC10% Owner5,894,897IndirectJun 21, 20230
Ally Bridge MedAlpha Master Fund L.P.10% Owner5,894,897IndirectJun 21, 20230
ABG Management Ltd.10% Owner5,894,897IndirectJun 21, 20230
ABG-WTT Global Life Science Capital Partners GP Ltd10% Owner5,894,897IndirectJun 21, 20230
ABG-WTT Global Life Science Capital Partners GP, L.P.10% Owner5,894,897IndirectJun 21, 20230
ABG WTT-MedAvail Ltd10% Owner5,894,897IndirectJun 21, 20230
McGraw LaurieDirector–Jun 20, 20230
Kramer Michael RDirector–Jun 20, 20230
Stettin Glen D.Director–Jun 20, 20230
Johnson Paul DDirector–Jun 20, 20230
Gradwell GeraldDirector–Jun 16, 20220
Hess StevenExecutive Vice President–Apr 12, 20220
Ciesielski HelenDirector–Jan 19, 20220
Kilroy EdwinChief Executive Officer–Jan 19, 20220
van Hamel Platerink GerardDirector–Jan 12, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 2, 2023 (view filing)Sep 284 daysSeabaugh RamonaChief Financial OfficerSSale−303$5.70−$1.73K−19.9%1.22K after10b5-1
Mar 23, 2023 (view filing)8:16 PM ETMar 212 daysSeabaugh RamonaChief Financial OfficerSSale−3.29K$0.307−$1.01K−15.2%18.3K after
Mar 15, 2023 (view filing)4:30 PM ETMar 132 daysYu Fan and 7 others10% OwnerPPurchase+7.78M$0.3212+$2.50M–965.1K afterDerivative2 lots
Mar 7, 2023 (view filing)7:55 PM ETMar 34 daysSeabaugh RamonaChief Financial OfficerSSale−6.73K$0.3366−$2.26K−23.7%21.6K after
Mar 7, 2023 (view filing)7:54 PM ETMar 3-64 daysDoerr Mark EdwardChief Executive OfficerSSale−93.6K$0.3145−$29.4K−33.1%188.7K after2 lots
Apr 6, 2022 (view filing)4:30 PM ETApr 42 daysYu Fan and 7 others10% OwnerPPurchase+14.1M$1.06+$15.0MNew position5.89M after2 lots
Apr 6, 2022 (view filing)4:30 PM ETApr 42 daysYu Fan and 7 others10% OwnerPPurchase+7.06M$1.06+$7.50M–1.49M afterDerivative2 lots